Leonteq Securities AG’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$195K Sell
64,000
-1,000
-2% -$2.99K 0.01% 575
2026
Q1
$200K Buy
65,000
+64,000
+6,400% +$272K 0.01% 599
2025
Q4
$3.61K Buy
+1,000
New +$4.36K ﹤0.01% 1280
2024
Q2
Sell
-500
Closed -$5.09K 1199
2024
Q1
$5.09K Buy
500
+200
+67% +$2.03K ﹤0.01% 1078
2023
Q4
$3.38K Buy
+300
New +$1.25K ﹤0.01% 1102

Other funds holding ALT

Leonteq Securities AG's ALT Position: Q2 2026 in Review

Leonteq Securities AG reduced its Altimmune (ALT) stake by 1.5% in Q2 2026, selling an estimated $2.99K and leaving 64,000 shares worth $195K. The position accounts for 0.01% of the portfolio, ranked #575.

Leonteq Securities AG first reported a position in ALT in Q4 2023 and has held it in 5 quarters since. The position peaked at $200K in Q1 2026. 208 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • Leonteq Securities AG held 64,000 shares of Altimmune worth $195K as of Q2 2026.
  • Leonteq Securities AG sold 1,000 Altimmune shares in Q2 2026, an estimated $2.99K.
  • Altimmune made up 0.01% of Leonteq Securities AG's portfolio in Q2 2026, its #575 holding.
  • Leonteq Securities AG first reported a position in Altimmune in Q4 2023 and has held it in 5 quarters since.
  • Leonteq Securities AG's Altimmune position peaked at $200K in Q1 2026.
  • 208 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.